Chemoprevention of Head and Neck Cancer by Green Tea Extract: EGCG—The Role of EGFR Signaling and “Lipid Raft”
2011

Chemoprevention of Head and Neck Cancer by Green Tea Extract: EGCG

Sample size: 41 publication Evidence: moderate

Author Information

Author(s): Masuda Muneyuki, Wakasaki Takahiro, Toh Satoshi, Shimizu Masahito, Adachi Seiji

Primary Institution: Kyushu Koseinenkin Hospital

Hypothesis

Can green tea extract, specifically EGCG, effectively prevent head and neck squamous cell carcinoma (HNSCC)?

Conclusion

EGCG shows promise as a chemopreventive agent for HNSCC, demonstrating clinical efficacy and unique biological effects.

Supporting Evidence

  • EGCG administration showed significantly higher response rates in high-dose groups compared to lower doses and placebo.
  • EGCG inhibited the incidence of second metachronous colon adenoma in treated patients.
  • Patients with high-grade prostate intraepithelial neoplasia had a lower incidence of prostate cancer when treated with EGCG.

Takeaway

Drinking green tea might help prevent a type of throat cancer by using a special ingredient called EGCG.

Methodology

The study reviewed various trials and evidence regarding the effects of EGCG on patients with high-risk oral premalignant lesions and other cancers.

Limitations

The clinical efficacy of EGCG is still debated due to varying concentrations used in studies compared to those achievable in humans.

Participant Demographics

Patients with high-risk oral premalignant lesions and other malignancies.

Statistical Information

P-Value

p = .03

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2011/540148

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication